Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate DTC Bill Is Latest Candidate For Inclusion In Bioterrorism Conference

Executive Summary

A Senate Democratic proposal to limit direct-to-consumer advertising is the latest pharmaceutical bill whose sponsors hope to use the bioterrorism conference measure as a vehicle for enactment

You may also be interested in...



FDA Commercial Speech Restrictions Could Hold Up In Court, Agency Says

FDA could still enforce restrictions on commercial speech even in light of the recent Supreme Court decision striking down limits on pharmacy advertising of compounding, FDA Associate Chief Counsel Patricia Kaeding said

FDA Commercial Speech Restrictions Could Hold Up In Court, Agency Says

FDA could still enforce restrictions on commercial speech even in light of the recent Supreme Court decision striking down limits on pharmacy advertising of compounding, FDA Associate Chief Counsel Patricia Kaeding said

PBM Quality Comparisons Feature In Senate Dems’ Medicare Rx Bill

PBMs delivering a drug benefit under Medicare would be subject to quality and consumer satisfaction comparisons under Sen. Bob Graham's (D-Fla.) Medicare Rx bill

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS039838

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel